Short communicationConditional cannabinoid receptor type 1 mutants reveal neuron subpopulation-specific effects on behavioral and neuroendocrine stress responses
Introduction
Endocannabinoids are fatty acid derivatives that can act as retrograde messengers in the nervous system by activation of presynaptically located cannabinoid receptor type 1 (CB1) (Piomelli, 2003). CB1 is one of the most abundant and widely expressed G-protein coupled neuronal receptors (Piomelli, 2003). It is located on both GABAergic and glutamatergic synapses where it suppresses inhibitory and excitatory neurotransmission (Monory et al., 2006). Therefore, the endocannabinoid system forms an intricate and complex neuromodulatory network that controls neuronal circuits of different nature at multiple sites (Piomelli, 2003, Monory et al., 2006).
CB1 expression is present in many brain regions involved in stress processing (Marsicano and Lutz, 1999, Piomelli, 2003), and significant interactions between endocannabinoid signaling and stress responses have been reported (Viveros et al., 2005). CB1 signaling is not only involved in the neuroendocrine (Patel et al., 2004, Steiner et al., 2008a), but also in the behavioral response to stress (Viveros et al., 2005, Steiner et al., 2008a). Although the use of complete CB1 knockout mice together with pharmacological approaches allowed the clear identification of endocannabinoid-mediated stress effects (Steiner et al., 2008a), the cellular substrates of these effects with regard to brain areas and neuronal subpopulations involved (e.g., GABAergic versus glutamatergic neurons) has remained unexplored.
Conditional CB1 knockout animals generated by using the Cre/loxP system, leading to a lack of CB1 in certain neuronal subpopulations (Marsicano et al., 2003, Monory et al., 2006, Monory et al., 2007), constitute an important tool to answer these questions. We have used three conditional CB1-mutant lines, lacking CB1 either in cortical glutamatergic neurons, in principal forebrain neurons or in GABAergic neurons, respectively, to investigate the differential roles of CB1 signaling in these neuronal subpopulations on neuroendocrine and behavioral stress coping in response to the forced swim test (FST), one of the most widely used paradigms in rodents to detect antidepressant-like effects of novel drugs and depression-like behavior of mutant mice (Cryan and Holmes, 2005).
Section snippets
Animals
Male mice (2–4 months old) were kept under standard conditions with food and water ad libitum under a 12 h:12 h inverted light/dark schedule (lights off at 09.00 h). Animals were separated and single housed 2 weeks prior to experiments. Mutants were obtained using the Cre/loxP system. Floxed CB1 mice (Marsicano et al., 2003) were crossed with Cre-recombinase expressing mouse lines (CaMKIIα-Cre, NEX-Cre, Dlx5/6-Cre), obtaining CaMK-CB1, Glu-CB1 and GABA-CB1-mutant lines as described (Marsicano et
Genetic deletion of CB1 in cortical glutamatergic neurons leads to decreased immobility behavior in the FST
Conditional CB1 mutants were subjected to forced swimming in two consecutive sessions on day 1 and on day 2 (Fig. 1). With respect to long-term changes in immobility from day 1 to day 2, all three conditional lines showed a general increase in immobility on day 2 [Day: F1,26 = 20.75, p < 0.001, for CaMK-CB1; F1,35 = 46.27, p < 0.001, for Glu-CB1; F1,22 = 36.32, p < 0.001, for GABA-CB1; two-way ANOVAs (Genotype, Day) for repeated measures (Day) performed separately for each strain; Fig. 1a, c, and e],
Discussion
CB1 is more prominently expressed in GABAergic neurons than in glutamatergic principal neurons (Marsicano and Lutz, 1999). Interestingly, however, levels of CB1 expression do not necessarily correlate with functional importance. CB1 signaling on glutamatergic, but not on GABAergic neurons, accounts primarily for the behavioral effects induced by high dose of Δ9-tetrahydrocannabinol (Monory et al., 2007) as well as for endocannabinoid-mediated physiological protection against excitotoxic
Role of funding source
No funding source was involved in this study.
Conflict of interest
All authors declare to have no conflicts of interest.
Acknowledgements
We would like to thank Dr. Emilio Casanova and Dr. Günther Schütz for providing CaMKIIα-Cre mice, Dr. Mark Ekker and Dr. John Rubenstein for Dlx5/6-Cre mice, and Dr. Armin-Klaus Nave for NEX-Cre mice. We thank Tanja Orschmann, Barbara Wölfel, Martina Reents and Anja Mederer for excellent technical assistance, and Dr. Krisztina Monory for critically reading the manuscript.
References (21)
- et al.
Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress
Biol. Psychiatry
(2007) - et al.
Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents
Biol. Psychiatry
(2005) - et al.
The endocannabinoid system controls key epileptogenic circuits in the hippocampus
Neuron
(2006) - et al.
Antidepressant-like behavioral effects of impaired cannabinoid receptor type 1 signaling coincide with exaggerated corticosterone secretion in mice
Psychoneuroendocrinology
(2008) - et al.
Elevated levels of endocannabinoids and the CB1 receptor-mediated G-protein signaling in the prefrontal cortex of alcoholic suicide victims
Mol. Psychiatry
(2005) - et al.
Endocannabinoid system and stress and anxiety responses
Pharmacol. Biochem. Behav.
(2005) - et al.
Hardwiring the brain: endocannabinoids shape neuronal connectivity
Science
(2007) - et al.
The ascent of mouse: advances in modelling human depression and anxiety
Nat. Rev. Drug Discov.
(2005) - et al.
Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism
J. Neurosci.
(2003) - et al.
Involvement of the endocannabinoid system in the ability of long-term tricyclic antidepressant treatment to suppress stress-induced activation of the hypothalamic-pituitary–adrenal axis
Neuropsychopharmacology
(2006)